ArticleAmino acids2026
Modulatory effects of branched-chain amino acid supplementation on neuroendocrine disturbances following traumatic brain injury in rats.
Article in Amino acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI) is frequently accompanied by neuroendocrine disturbances involving the hypothalamic-pituitary-thyroid (HPT) axis and vitamin D-calcium-phosphorus homeostasis. Despite increasing interest in nutritional strategies after TBI, the effects of branched-chain amino acid (BCAA) supplementation on post-injury neuroendocrine homeostasis, including thyroid hormone levels, vitamin D status, and calcium-phosphorus balance, remain insufficiently characterized. Twenty-eight male Wistar rats were randomly assigned to Control, Sham, TBI, and TBI + BCAA groups. Moderate TBI was induced using a closed-head weight-drop model. BCAA (0.26 g/kg) was administered orally after injury. Motor function was assessed using balance beam and gait analysis, and serum levels of thyroid hormones, 25-hydroxyvitamin D, calcium, and phosphorus were measured. TBI induced a negative body weight change, impaired balance and gait, reduced serum thyroid hormones, 25-hydroxyvitamin D, calcium, and phosphorus levels, and decreased brain and hippocampal morphometric parameters. Post-injury BCAA supplementation significantly attenuated TBI-associated body weight loss and improved balance beam scores and gait parameters relative to the untreated TBI group. In addition, BCAA treatment partially restored serum thyroid hormones, 25-hydroxyvitamin D, calcium, and phosphorus levels, although values did not fully return to control levels. BCAA supplementation also partially attenuated TBI-induced changes in gross brain and hippocampal morphometric parameters. Post-injury BCAA supplementation exerted modulatory effects, as reflected by partial improvement in neuroendocrine parameters and motor performance. However, incomplete normalization indicates that BCAA supplementation supports metabolic and functional adaptation rather than full endocrine or structural recovery. These findings suggest that BCAAs may serve as a complementary nutritional strategy to mitigate post-TBI neuroendocrine dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.